Skip to content

Clinical trials

Parkinsonian Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Clear all

213 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20045
20051
20067
20085
20094
20102
20117
201210
20136
20147
20155
20162
201713
20189
201916
202015
202116
202213
202317
202416
202513
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Unknown status39
Recruiting35
Terminated14
Active, not recruiting9
Enrolling by invitation9
Not yet recruiting7
Withdrawn5
Suspended1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Neurodegenerative Disorders10
Adamas Pharmaceuticals, Inc.6
National Institute of Neurological Disorders and Stroke (NINDS)6
Ruijin Hospital6
Radboud University Medical Center5
AbbVie4
Fondazione Don Carlo Gnocchi ETS4
University College, London4
Dr WANG Shumei3
Fondazione Europea di Ricerca Biomedica Ferb Onlus3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders213
Parkinson Disease163
Movement Disorders40
Neurodegenerative Diseases36
Central Nervous System Diseases29
Brain Diseases27
Multiple System Atrophy25
Supranuclear Palsy, Progressive25
Nervous System Diseases24
Basal Ganglia Diseases20

Trials

Showing 1 to 25 of 213. Each trial links to its page on Pharma Observatory.

113 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.